漫画:贝叶斯剂量优化设计用于多种适应症的药物组合,适用于CAR-T疗法
Kai Chen1,2, Kentaro Takeda3, Ying Yuan2
1Department of Biostatistics and Data Science, The University of Texas Health Science Center, Houston, Texas, USA.
项目Optimus旨在找到最佳的药物剂量,但组合试验面临挑战. 在COMIC设计有效地确定最佳的生物剂量组合的多种适用性,减少样本大小的需求.
科学领域:
- 临床试验 临床试验
- 药学指标 (Pharmacometrics) 是一个指标.
- 生物统计学 生物统计学
背景情况:
- 项目Optimus旨在寻求最佳的药物剂量,以实现更好的风险效益平衡.
- 药物组合试验面临的挑战是有限的样本大小和复杂的剂量探索.
- 多种迹象加剧了剂量检测研究中的这些挑战.
研究的目的:
- 开发一个高效的贝叶斯剂量优化设计,用于药物组合在多种适应症.
- 为了确定最佳的生物剂量组合 (OBDC),同时解决样本大小的限制.
- 为了使 Project Optimus 的范式适应复杂的组合疗法试验.
主要方法:
- 引入了一个两阶段的贝叶斯设计:COMIC (多个指示中的组合优化).
- 阶段1:通过风险-收益效用函数,优化针对一个适应症的剂量.
- 第2阶段:利用第1阶段的数据来加快对额外的适用情况的剂量优化,并纳入药理动力学终点.
主要成果:
- 在COMIC设计显著减少了多指标组合试验所需的样本大小.
- 纳入药理动力学终点可以提高组合成分剂量升级的效率.
- 模拟研究证实了COMIC设计在各种场景中的强大性能和稳定性.
结论:
- 该COMIC设计提供了一个有效的解决方案,以优化药物组合在多指标试验.
- 这种方法有助于在资源限制下识别最佳生物剂量组合 (OBDC).
- 该方法适用于新型疗法,例如CAR-T疗法试验.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
09:12Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Analysis of Population Pharmacokinetic Data
Dose-Response Relationship: Overview
Drug Discovery: Overview
